Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | See Remarks | June 24, 2023 | June 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date June 24, 2023 · Filed June 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23 | Direct | 207,500 |
Reported balance
After 2023-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 510 | $89.06 | $45,418.46 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,577 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $88.81 to $89.78, inclusive. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 404 | $88.17 | $35,619.27 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,087 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $87.66 to $88.40, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,258 | $10.29 | $54,104.82 |
DisclosureSEC source: 0001209191-21-053158 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 22:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051487 · doc4.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 22:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $88.21 | $0.00 |
DisclosureSEC source: 0001209191-21-051487 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-08-12 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares vest one month after the Vesting Commencement Date (June 30, 2021); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,716 | $86.52 | $408,035.39 |
DisclosureSEC source: 0001209191-21-047756 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,233 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $86.09 to $86.89, inclusive. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,234 | $85.76 | $191,588.73 |
DisclosureSEC source: 0001209191-21-047756 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,949 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $85.085 to $86.085, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 21:38 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 845 | $86.07 | $72,728.56 |
DisclosureSEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,183 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $85.895 to $86.16, inclusive. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 21:38 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,359 | $85.45 | $287,030.24 |
DisclosureSEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,028 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $84.85 to $85.77, inclusive. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 21:38 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,884 | $84.39 | $158,999.24 |
DisclosureSEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,387 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $83.82 to $84.765, inclusive. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 21:38 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 387 | $83.39 | $32,273.75 |
DisclosureSEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,271 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $82.735 to $83.66, inclusive. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 21:38 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 475 | $82.22 | $39,053.41 |
DisclosureSEC source: 0001209191-21-042800 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,658 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $81.615 to $82.605, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| June 15, 2021 Filed Jun 15, 2021 23:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,147 | $84.75 | $97,208.25 |
DisclosureSEC source: 0001209191-21-040741 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,968 F3 · kind: The sale was made to cover tax withholding obligations in connection with vesting and settlement of 1/4th of the Reporting Person's performance-based RSU granted on December 30, 2019. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041809 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,857 Underlying: Common Stock · 3,619 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the RSU vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,454 | $80.90 | $117,624.24 |
DisclosureSEC source: 0001209191-21-041809 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,133 F2 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:26 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 3,619 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-041809 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040741 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Common Stock · 2,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 11,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040741 · doc4.xml · derivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,600 Underlying: Common Stock · 11,600 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. F4 · derivative.expiration_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 18,450 | $0.00 Strike: $73.51 | $0.00 |
DisclosureSEC source: 0001209191-21-040741 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,450 Underlying: Common Stock · 18,450 shares Expires 2029-12-29 F4 · derivative.exercise_date: On December 30, 2019 the Reporting Person was awarded a performance-based award. 1/4th of the award vested on June 11, 2021 upon the achievement of certain performance criteria ("Performance Achievement Date"); thereafter, the award will vest in three equal annual installments on each of the first, second, and third anniversaries of the Performance Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 2,900 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-040741 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F2 · balance_after: Includes 54 shares acquired under the 2018 Employee Stock Purchase Plan on May 31, 2021. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 397 | $82.53 | $32,764.41 |
DisclosureSEC source: 0001209191-21-035389 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,161 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $82.45 to $82.80, inclusive. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,490 | $81.77 | $121,841.77 |
DisclosureSEC source: 0001209191-21-035389 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,558 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $81.365 to $82.36, inclusive. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 5,063 | $80.85 | $409,318.24 |
DisclosureSEC source: 0001209191-21-035389 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,048 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $80.36 to $81.34, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,889 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032823 · doc4.xml · derivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,793 Underlying: Common Stock · 1,889 shares Expires 2028-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-sixtieth of the shares subject to the option vested on November 3, 2018, and 1/60th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,379 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-032823 · doc4.xml · derivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,546 Underlying: Common Stock · 5,379 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 1,889 | $10.00 | $18,890.00 |
DisclosureSEC source: 0001209191-21-032823 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 14, 2021 21:22 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 5,379 | $10.29 | $55,349.91 |
DisclosureSEC source: 0001209191-21-032823 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · derivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,925 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 182 | $114.97 | $20,925.07 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $114.68 to $115.33, inclusive. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 595 | $113.73 | $67,667.15 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,025 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $113.365 to $114.06, inclusive. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 669 | $112.15 | $75,029.82 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $111.88 to $112.58, inclusive. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,650 | $111.31 | $406,276.76 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,289 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $110.87 to $111.845, inclusive. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 621 | $110.37 | $68,541.38 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $109.845 to $110.84, inclusive. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,233 | $109.33 | $134,808.95 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,560 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $108.82 to $109.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 20:59 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-027961 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:07 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-022881 · doc4.xml · derivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,875 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:07 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 206 | $133.38 | $27,477.10 |
DisclosureSEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $133.37 to $133.46, inclusive. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:07 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 672 | $132.57 | $89,086.37 |
DisclosureSEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,049 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $132.165 to $132.71, inclusive. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:07 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,088 | $131.71 | $538,434.57 |
DisclosureSEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,721 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $131.09 to $132.08, inclusive. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:07 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,984 | $130.49 | $258,896.13 |
DisclosureSEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,809 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $130.04 to $130.94, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 21:07 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-21-022881 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-018320 · doc4.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,825 Underlying: Common Stock · 12,500 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 12,500 | $10.29 | $128,625.00 |
DisclosureSEC source: 0001209191-21-018320 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · derivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,325 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 413 | $129.18 | $53,349.61 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,343 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $128.75 to $129.45, inclusive. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,827 | $127.34 | $232,650.36 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,756 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $126.99 to $127.92, inclusive. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,611 | $125.97 | $202,940.73 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,583 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $125.67 to $126.628, inclusive. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,150 | $124.92 | $268,573.92 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,194 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $124.47 to $125.32, inclusive. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 687 | $123.56 | $84,888.61 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,344 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $123.28 to $124.20, inclusive. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:44 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 262 | $122.00 | $31,963.66 |
DisclosureSEC source: 0001209191-21-013834 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,031 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $121.86 to $122.65, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.